Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
5,135
+577
+13% +$124K 0.01% 1437
2026
Q1
$1.01M Buy
4,558
+1,655
+57% +$405K 0.01% 1403
2025
Q4
$736K Buy
2,903
+33
+1% +$8.29K 0.01% 688
2025
Q3
$710K Sell
2,870
-34
-1% -$8.14K 0.01% 1279
2025
Q2
$698K Buy
2,904
+601
+26% +$140K 0.01% 1208
2025
Q1
$522K Buy
2,303
+319
+16% +$70.2K 0.01% 1201
2024
Q4
$408K Buy
1,984
+63
+3% +$13.8K 0.01% 1254
2024
Q3
$466K Buy
1,921
+39
+2% +$9.12K 0.01% 1113
2024
Q2
$413K Buy
1,882
+153
+9% +$33.2K 0.01% 1108
2024
Q1
$389K Buy
1,729
+592
+52% +$134K 0.01% 1135
2023
Q4
$250K Buy
1,137
+124
+12% +$26.2K 0.01% 1159
2023
Q3
$222K Buy
+1,013
New +$229K 0.01% 1124

Other funds holding STE

Empowered Funds's STE Position: Q2 2026 in Review

Empowered Funds increased its Steris (STE) stake by 13% in Q2 2026, buying an estimated $124K and bringing the position to 5,135 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #1437.

Empowered Funds first reported a position in STE in Q3 2023 and has held it in 12 quarters since. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Empowered Funds held 5,135 shares of Steris worth $1.08M as of Q2 2026.
  • Empowered Funds bought 577 Steris shares in Q2 2026, an estimated $124K.
  • Steris made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1437 holding.
  • Empowered Funds first reported a position in Steris in Q3 2023 and has held it in 12 quarters since.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.